Polaris Capital Management’s Harmony Biosciences HRMY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.01M	Hold	36,100	–	–	0.08%	77
2025 Q4	$1.35M	Hold	36,100	–	–	0.11%	71
2025 Q3	$995K	Hold	36,100	–	–	0.07%	80
2025 Q2	$1.14M	Hold	36,100	–	–	0.08%	81
2025 Q1	$1.2M	Sell	36,100 -22,200	-38%	-$796K	0.07%	76
2024 Q4	$2.01M	Buy	58,300 +13,300	+30%	+$457K	0.1%	56
2024 Q3	$1.8M	Buy	45,000 +16,500	+58%	+$580K	0.09%	66
2024 Q2	$860K	Hold	28,500	–	–	0.05%	83
2024 Q1	$957K	Hold	28,500	–	–	0.05%	80
2023 Q4	$921K	Sell	28,500 -7,600	-21%	-$212K	0.04%	82
2023 Q3	$1.18M	Hold	36,100	–	–	0.06%	70
2023 Q2	$1.27M	Hold	36,100	–	–	0.05%	74
2023 Q1	$1.18M	Buy	36,100 +4,300	+14%	+$196K	0.04%	75
2022 Q4	$1.75M	Buy	31,800 +3,300	+12%	+$181K	0.06%	55
2022 Q3	$1.26M	Hold	28,500	–	–	0.05%	63
2022 Q2	$1.39M	Sell	28,500 -2,400	-8%	-$108K	0.05%	57
2022 Q1	$1.5M	Hold	30,900	–	–	0.05%	62
2021 Q4	$1.32M	Hold	30,900	–	–	0.04%	71
2021 Q3	$1.18M	Hold	30,900	–	–	0.04%	78
2021 Q2	$872K	Buy	+30,900	New	+$927K	0.03%	92